Acurx Pharmaceuticals Inc... (ACXP)

AI Score

Unlock

0.37

-0.02 (-3.92%)

At close: Apr 17, 2025, 3:59 PM

0.39

5.02%

After-hours: Apr 17, 2025, 04:54 PM EDT

Acurx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-14.1M	-16.44M	-16.73M	-16.05M	-14.58M	-12.72M	-13.15M	-12.33M	-12.09M	-11.46M	-12.56M	-13.94M	-12.75M	-11.21M	-7.89M	-4.8M	-4.6M	-3.51M	-2.19M	-1.28M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	3.07M	3.76M	4.28M	4.07M	3.77M	3.24M	3.23M	3.14M	3.19M	3.25M	5.82M	7.36M	6.74M	6.27M	3.18M	1.25M	1.27M	982.17K	675.53K	347.77K
Other Working Capital	-225.06K	-481.99K	-167.92K	925.79K	-11.36M	-11.31M	-10.96M	-11.74M	211.28M	211.53M	210.8M	212M	971.26K	951.97K	1.14M	-340.81K	-506	40.01K	34.73K	35.34K
Other Non-Cash Items	1.77M	2.16M	2.55M	3.1M	2.93M	3.35M	3.34M	3.25M	3.3M	3.25M	2.47M	1.69M	1.66M	784.35K	1.11M	1.19M	1.06M	1.17M	795.25K	781.7K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-49.65K	-352.83K	-38.76K	1.05M	1.01M	2.27M	2.62M	1.47M	1.25M	662.42K	-1.27M	302.96K	141.28K	-377.96K	1.26M	-368.22K	-801.17K	-648.67K	-897.81K	-749.66K
Operating Cash Flow	-10.38M	-12.33M	-12.23M	-10.93M	-9.8M	-7.1M	-7.19M	-7.6M	-7.54M	-7.55M	-8M	-6.34M	-5.01M	-4.47M	-2.6M	-3M	-3.35M	-2.39M	-1.63M	-899.29K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	66.5K	66.5K	66.5K	66.5K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	6.42B	6.42B	4.83M	4.83M	4.62M	-3.7M	86.00	13.00	13.00	14.79B	14.78B	14.78B	14.78B	n/a	n/a	1.06M	1.06M	1.06M	1.06M	n/a
Financial Cash Flow	6.42B	6.43B	9.45M	12.67M	8.16M	3.54M	7.24M	3.7M	3.7M	14.79B	14.78B	14.8B	14.8B	15.53M	17.72M	4.04M	4.04M	3.32M	1.12M	n/a
Net Cash Flow	-3.77M	-1.29M	-2.78M	-8.98M	-12.36M	-14.28M	-10.67M	-3.9M	-3.85M	-3.85M	-8M	8.45M	9.78M	11.05M	15.12M	1.04M	692.09K	923.31K	-508.88K	-899.29K
Free Cash Flow	-10.38M	-12.33M	-12.23M	-10.93M	-9.8M	-7.1M	-7.19M	-7.6M	-7.54M	-7.55M	-8M	-6.34M	-5.01M	-4.47M	-2.6M	-3M	-3.35M	-2.39M	-1.63M	-899.29K